1 documents found
Information × Registration Number 0115U000673, R & D request Title International, many centers, randomized, double-blind, placebo-controlled, parallel-group in the study to assess the efficacy and safety of treatment teriflunomide 7 mg once daily, 14 mg daily compared with placebo over two years in patients with a first clinical manifestation of multiple suspect sclerosis Head Lytvynenko Nataliia , Доктор медичних наук Registration Date 02-03-2015 Organization Ukrainian medical stomatological Academy popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
International, many centers, randomized, double-blind, placebo-controlled, parallel-group in the study to assess the efficacy and safety of treatment teriflunomide 7 mg once daily, 14 mg daily compared with placebo over two years in patients with a first clinical manifestation of multiple suspect sclerosis
Head: Lytvynenko Nataliia . International, many centers, randomized, double-blind, placebo-controlled, parallel-group in the study to assess the efficacy and safety of treatment teriflunomide 7 mg once daily, 14 mg daily compared with placebo over two years in patients with a first clinical manifestation of multiple suspect sclerosis. Ukrainian medical stomatological Academy. № 0115U000673
1 documents found

Updated: 2026-03-25


Роздрукувати цю сторінку